Search in:

mAbs Volume 7, 2015 - Issue 1

Submit an article Journal homepage

Free access

1,186

Views

CrossRef citations to date

Altmetric

Report

Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal disease

Diane E MilenicRadioimmune & Inorganic Chemistry Section; Radiation Oncology Branch; Center for Cancer Research; National Cancer Institute; National Institutes of Health; BethesdaMDUSACorrespondence[email protected]

Kwamena E BaidooRadioimmune & Inorganic Chemistry Section; Radiation Oncology Branch; Center for Cancer Research; National Cancer Institute; National Institutes of Health; BethesdaMDUSA

Young-Seung KimRadioimmune & Inorganic Chemistry Section; Radiation Oncology Branch; Center for Cancer Research; National Cancer Institute; National Institutes of Health; BethesdaMDUSA

Martin W BrechbielRadioimmune & Inorganic Chemistry Section; Radiation Oncology Branch; Center for Cancer Research; National Cancer Institute; National Institutes of Health; BethesdaMDUSA

Pages 255-264 | Received 05 Aug 2014, Accepted 06 Oct 2014, Published online: 14 Jan 2015

Cite this article
https://doi.org/10.4161/19420862.2014.985160
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions
View PDF PDF

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (27)

Katherine A. Morgan, Stacey E. Rudd, Asif Noor & Paul S. Donnelly. (2023) Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides. Chemical Reviews 123:20, pages 12004-12035.
Crossref

Anna Julie Kjøl Tornes, Vilde Yuli Stenberg, Roy Hartvig Larsen, Øyvind Sverre Bruland, Mona-Elisabeth Revheim & Asta Juzeniene. (2022) Targeted alpha therapy with the 224Ra/212Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma. Frontiers in Medicine 9.
Crossref

Konstantin V. Kokov, Bayirta V. Egorova, Marina N. German, Ilya D. Klabukov, Michael E. Krasheninnikov, Antonius A. Larkin-Kondrov, Kseniya A. Makoveeva, Michael V. Ovchinnikov, Maria V. Sidorova & Dmitry Y. Chuvilin. (2022) 212Pb: Production Approaches and Targeted Therapy Applications. Pharmaceutics 14:1, pages 189.
Crossref

Zacharenia Nikitaki, Anastasia Velalopoulou, Vassiliki Zanni, Ioanna Tremi, Sophia Havaki, Michael Kokkoris, Vassilis G. Gorgoulis, Constantinos Koumenis & Alexandros G. Georgakilas. (2022) Key biological mechanisms involved in high-LET radiation therapies with a focus on DNA damage and repair. Expert Reviews in Molecular Medicine 24.
Crossref

Federica Guidoccio, Sara Mazzarri, Tommaso Depalo, Federica Orsini, Paola A. Erba & Giuliano Mariani. 2020. Nuclear Oncology. Nuclear Oncology 1 27 .

Federica Guidoccio, Sara Mazzarri, Tommaso Depalo, Federica Orsini, Paola A. Erba & Giuliano Mariani. 2022. Nuclear Oncology. Nuclear Oncology 217 243 .

Julie Rousseau, Joseph Lau & François Bénard. 2022. Nuclear Medicine and Immunology. Nuclear Medicine and Immunology 297 345 .

Mathilde Allard, Justine Perrin, Yannick Guilloux, Françoise Kraeber-Bodéré, Michel Chérel & Joëlle Gaschet. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 24 .

Ruth Gong Li, Kim Lindland, Tina Bjørnlund Bønsdorff, Sara Westrøm & Roy Hartvig Larsen. (2021) A Novel Single-Step-Labeled 212Pb-CaCO3 Microparticle for Internal Alpha Therapy: Preparation, Stability, and Preclinical Data from Mice. Materials 14:23, pages 7130.
Crossref

A. A. Rosenkranz & T. A. Slastnikova. (2020) Epidermal Growth Factor Receptor: Key to Selective Intracellular Delivery. Biochemistry (Moscow) 85:9, pages 967-993.
Crossref

Hossein Jadvar. (2020) Targeted α-Therapy in Cancer Management: Synopsis of Preclinical and Clinical Studies. Cancer Biotherapy and Radiopharmaceuticals 35:7, pages 475-484.
Crossref

Astri Fjelde Maaland, Amal Saidi, Julien Torgue, Helen Heyerdahl, Tania A. Rozgaja Stallons, Arne Kolstad & Jostein Dahle. (2020) Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003. PLOS ONE 15:3, pages e0230526.
Crossref

Garima Singh, Kristof Zarschler, Sebastian Hunoldt, Irma Ivette Santana Martínez, Carmen L. Ruehl, Madlen Matterna, Ralf Bergmann, Domokos Máthé, Nikolett Hegedüs, Michael Bachmann, Peter Comba & Holger Stephan. (2020) Versatile Bispidine‐Based Bifunctional Chelators for 64 Cu II ‐Labelling of Biomolecules . Chemistry – A European Journal 26:9, pages 1989-2001.
Crossref

Narges K. Tafreshi, Michael L. Doligalski, Christopher J. Tichacek, Darpan N. Pandya, Mikalai M. Budzevich, Ghassan El-Haddad, Nikhil I. Khushalani, Eduardo G. Moros, Mark L. McLaughlin, Thaddeus J. Wadas & David L. Morse. (2019) Development of Targeted Alpha Particle Therapy for Solid Tumors. Molecules 24:23, pages 4314.
Crossref

Maryline G. Ferrier, Valery Radchenko & D. Scott Wilbur. (2019) Radiochemical aspects of alpha emitting radionuclides for medical application. Radiochimica Acta 107:9-11, pages 1065-1085.
Crossref

Christian A. Mason, Lukas M. Carter & Jason S. Lewis. 2019. Metal-based Anticancer Agents. Metal-based Anticancer Agents 271 307 .

Sophie Poty, Lynn C. Francesconi, Michael R. McDevitt, Michael J. Morris & Jason S. Lewis. (2018) α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 2. Journal of Nuclear Medicine 59:7, pages 1020-1027.
Crossref

Diane E. MilenicYoung-Seung KimKwamena E. BaidooKaren J. WongRachel BarkleyJose DelgadoMartin W. Brechbiel. (2018) Exploration of a F(ab′) 2 Fragment as the Targeting Agent of α-Radiation Therapy: A Comparison of the Therapeutic Benefit of Intraperitoneal and Intravenous Administered Radioimmunotherapy . Cancer Biotherapy and Radiopharmaceuticals 33:5, pages 182-193.
Crossref

Diane E. Milenic, Kwamena E. Baidoo, Young-Seung Kim, Rachel Barkley & Martin W. Brechbiel. (2017) Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab. Translational Oncology 10:4, pages 535-545.
Crossref

Benjamin B. Kasten, Rebecca C. Arend, Ashwini A. Katre, Harrison Kim, Jinda Fan, Soldano Ferrone, Kurt R. Zinn & Donald J. Buchsbaum. (2017) B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models. Nuclear Medicine and Biology 47, pages 23-30.
Crossref

Sadaf Aghevlian, Amanda J. Boyle & Raymond M. Reilly. (2017) Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons. Advanced Drug Delivery Reviews 109, pages 102-118.
Crossref

Federica Guidoccio, Sara Mazzarri, Federica Orsini, Paola Anna Erba & Giuliano Mariani. 2017. Nuclear Oncology. Nuclear Oncology 173 198 .

Benjamin B. Kasten, Michael T. Azure, Trenton R. Schoeb, Darrell R. Fisher & Kurt R. Zinn. (2016) Imaging, biodistribution, and toxicology evaluation of 212Pb-TCMC-trastuzumab in nonhuman primates. Nuclear Medicine and Biology 43:7, pages 391-396.
Crossref

Patricia S. Steeg. (2016) Targeting metastasis. Nature Reviews Cancer 16:4, pages 201-218.
Crossref

Federica Guidoccio, Sara Mazzarri, Federica Orsini, Paola A. Erba & Giuliano Mariani. 2016. Nuclear Oncology. Nuclear Oncology 1 26 .

Clara Panosa, Humphrey Fonge, Montserrat Ferrer-Batallé, Javier A. Menéndez, Anna Massaguer, Rafael De Llorens & Raymond M. Reilly. (2015) A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111 In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice. Nuclear Medicine and Biology 42:12, pages 931-938.
Crossref

Diane Milenic, Alfredo Molinolo, María Solivella, Eileen Banaga, Julien Torgue, Sarah Besnainou, Martin Brechbiel & Kwamena Baidoo. (2015) Toxicological Studies of 212Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial. Pharmaceuticals 8:3, pages 416-434.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal disease

Articles from other publishers (27)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal disease

Citations (27)

Articles from other publishers (27)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date